Success Stories: NIW Granted for Breakthrough Research in Tumor Immunology and T Cell Modulation

Client’s Testimonial:

“I am truly grateful to the North America Immigration Law Group (NAILG) for their professional and meticulous support throughout my EB-2 NIW petition process. They demonstrated a deep understanding of both immigration law and the scientific relevance of my research. What stood out most was their rigorous attention to detail—they carefully reviewed every word of my documents to ensure clarity, accuracy, and compliance. Every time I had a question, they responded promptly and professionally, which gave me great peace of mind. ”

On April 3^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Immunotherapy (Approval Notice).

General Field: Immunotherapy

Position at the Time of Case Filing: Staff Scientist

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: April 3^rd, 2025

Processing Time: 11 months, 24 days

Case Summary:

Our client’s work in the field of immunotherapy stands at the intersection of innovation and clinical relevance. Her proposed endeavor focuses on advancing the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions by leveraging high-throughput technologies such as single-cell sequencing. Through this approach, she examines T cell behavior within tumor microenvironments and the immune responses elicited by cancer treatments and vaccines.

By combining advanced immunoprofiling techniques with in vitro and in vivo immune assays, our client’s research enables the evaluation of current treatment efficacy and helps identify novel, cost-effective strategies to modulate immune responses. Her contributions support not only therapeutic innovation but also the development of more accessible treatment pathways, an outcome of clear national interest.

In recognition of the public health value of her work, she has received funding support from prominent federal agencies, including the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI). These grants reflect the significance and impact of her scientific inquiries in addressing some of the nation’s most challenging diseases.

To further her research in the United States, our client retained the North America Immigration Law Group (NAILG) to pursue a National Interest Waiver (NIW) petition. NAILG’s legal team presented a petition emphasizing the originality of her contributions and their alignment with pressing healthcare priorities. Rather than relying solely on theoretical advancements, the petition highlighted her practical impact through:

● 14 peer-reviewed journal articles, including 4 first-authored and 3 co-first-authored

● 411 total citations, marking her growing influence in the immunotherapy research community

● 20+ peer reviews, showcasing her role in advancing scientific discourse and quality assurance

The strength of her petition was further reinforced by expert support. As one recommender wrote:

“To conclude, [client]’s leadership in immunotherapy is clearly demonstrated by her commitment to the development of effective inflammatory treatments that do not compromise normal immunity. There is thus no doubt that [client] shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns.”

With the NIW approved, our client is now positioned to continue her work on T cell-driven immunotherapies and immune system modulation, fields that are vital not only to biomedical progress but to national health outcomes and scientific leadership on a global scale.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.